Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Catatonia | 29 | 2023 | 157 | 7.050 |
Why?
|
Psychiatry | 15 | 2022 | 1695 | 1.870 |
Why?
|
Mind-Body Therapies | 13 | 2022 | 247 | 1.830 |
Why?
|
Neuropsychiatry | 3 | 2019 | 55 | 1.440 |
Why?
|
Neurology | 4 | 2022 | 762 | 1.290 |
Why?
|
Electroconvulsive Therapy | 7 | 2022 | 472 | 1.230 |
Why?
|
Psychosomatic Medicine | 4 | 2014 | 75 | 1.160 |
Why?
|
Fibromyalgia | 2 | 2023 | 388 | 1.140 |
Why?
|
Meditation | 7 | 2022 | 242 | 1.120 |
Why?
|
Anti-Anxiety Agents | 7 | 2012 | 390 | 1.120 |
Why?
|
Neuroleptic Malignant Syndrome | 3 | 2023 | 71 | 1.030 |
Why?
|
Morphine | 13 | 2008 | 657 | 0.980 |
Why?
|
Delusions | 3 | 2022 | 300 | 0.940 |
Why?
|
Relaxation | 7 | 2018 | 50 | 0.930 |
Why?
|
Burnout, Professional | 4 | 2021 | 690 | 0.920 |
Why?
|
Lorazepam | 7 | 2023 | 145 | 0.910 |
Why?
|
Anxiety Disorders | 8 | 2012 | 2684 | 0.810 |
Why?
|
Delirium | 11 | 2022 | 1608 | 0.780 |
Why?
|
Prisoners | 2 | 2021 | 296 | 0.770 |
Why?
|
Mental Disorders | 14 | 2022 | 6587 | 0.750 |
Why?
|
Stress, Psychological | 22 | 2021 | 4229 | 0.720 |
Why?
|
Refugees | 2 | 2017 | 510 | 0.720 |
Why?
|
Health Personnel | 4 | 2021 | 3210 | 0.710 |
Why?
|
Depressive Disorder, Major | 8 | 2017 | 4628 | 0.690 |
Why?
|
Antipsychotic Agents | 9 | 2023 | 3058 | 0.690 |
Why?
|
Psychophysiologic Disorders | 4 | 2014 | 228 | 0.670 |
Why?
|
Depression | 22 | 2022 | 7733 | 0.620 |
Why?
|
Resilience, Psychological | 6 | 2022 | 665 | 0.600 |
Why?
|
Fatigue | 3 | 2021 | 1526 | 0.590 |
Why?
|
Adaptation, Psychological | 12 | 2021 | 2575 | 0.580 |
Why?
|
Auditory Pathways | 1 | 2019 | 233 | 0.580 |
Why?
|
Hospitals, General | 5 | 2021 | 749 | 0.580 |
Why?
|
Psychomotor Agitation | 4 | 2019 | 288 | 0.570 |
Why?
|
Tinnitus | 1 | 2019 | 195 | 0.550 |
Why?
|
Empathy | 3 | 2016 | 472 | 0.550 |
Why?
|
Basal Ganglia | 2 | 2019 | 545 | 0.550 |
Why?
|
Counterpulsation | 3 | 2002 | 19 | 0.550 |
Why?
|
Tai Ji | 3 | 2017 | 284 | 0.550 |
Why?
|
Correspondence as Topic | 1 | 2016 | 27 | 0.540 |
Why?
|
Needs Assessment | 2 | 2017 | 1146 | 0.520 |
Why?
|
Veterans | 4 | 2021 | 2513 | 0.510 |
Why?
|
Religion and Psychology | 2 | 2015 | 171 | 0.510 |
Why?
|
Auditory Cortex | 1 | 2019 | 346 | 0.510 |
Why?
|
Myocardial Infarction | 9 | 2010 | 11690 | 0.510 |
Why?
|
Grief | 2 | 2022 | 247 | 0.500 |
Why?
|
Thalamus | 2 | 2019 | 1023 | 0.500 |
Why?
|
Opioid Peptides | 7 | 2017 | 42 | 0.500 |
Why?
|
Humans | 200 | 2023 | 742088 | 0.490 |
Why?
|
Muscle Relaxants, Central | 1 | 2014 | 86 | 0.480 |
Why?
|
Affective Symptoms | 5 | 2018 | 407 | 0.470 |
Why?
|
Neurosciences | 1 | 2018 | 347 | 0.460 |
Why?
|
Relaxation Therapy | 5 | 2018 | 178 | 0.450 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 2 | 2022 | 895 | 0.440 |
Why?
|
Receptors, Opioid, mu | 6 | 2008 | 182 | 0.440 |
Why?
|
Family Practice | 1 | 2016 | 516 | 0.440 |
Why?
|
Psychotic Disorders | 8 | 2022 | 3040 | 0.430 |
Why?
|
Gyrus Cinguli | 1 | 2019 | 1088 | 0.430 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 4 | 2017 | 1953 | 0.420 |
Why?
|
Limbic Encephalitis | 1 | 2012 | 34 | 0.420 |
Why?
|
Granulocytes | 4 | 1998 | 546 | 0.420 |
Why?
|
Hydrocephalus, Normal Pressure | 1 | 2013 | 92 | 0.410 |
Why?
|
Mentors | 3 | 2015 | 630 | 0.410 |
Why?
|
Adenovirus Infections, Human | 1 | 2012 | 71 | 0.410 |
Why?
|
Program Development | 2 | 2020 | 1314 | 0.400 |
Why?
|
Personality Inventory | 5 | 2010 | 1026 | 0.390 |
Why?
|
Arrhythmias, Cardiac | 6 | 2011 | 2267 | 0.390 |
Why?
|
Clozapine | 3 | 2023 | 498 | 0.390 |
Why?
|
Nervous System Diseases | 6 | 2019 | 1617 | 0.380 |
Why?
|
Anxiety | 13 | 2022 | 4279 | 0.380 |
Why?
|
GABA Modulators | 2 | 2010 | 107 | 0.370 |
Why?
|
Depressive Disorder | 8 | 2018 | 3748 | 0.370 |
Why?
|
Capacity Building | 2 | 2016 | 248 | 0.370 |
Why?
|
Physician's Role | 2 | 2016 | 942 | 0.360 |
Why?
|
Nitric Oxide | 11 | 2013 | 2128 | 0.360 |
Why?
|
Encephalitis | 2 | 2015 | 423 | 0.350 |
Why?
|
Yoga | 3 | 2022 | 253 | 0.330 |
Why?
|
Stress, Physiological | 9 | 2013 | 1402 | 0.330 |
Why?
|
Loneliness | 2 | 2021 | 184 | 0.320 |
Why?
|
Epilepsy, Complex Partial | 1 | 2008 | 62 | 0.320 |
Why?
|
Haloperidol | 3 | 2010 | 397 | 0.320 |
Why?
|
Pilot Projects | 14 | 2021 | 8297 | 0.310 |
Why?
|
Mental Health | 7 | 2022 | 2997 | 0.300 |
Why?
|
Syria | 2 | 2017 | 75 | 0.300 |
Why?
|
Anticonvulsants | 1 | 2017 | 1914 | 0.300 |
Why?
|
Neuroimmunomodulation | 3 | 2008 | 152 | 0.300 |
Why?
|
Lebanon | 2 | 2017 | 227 | 0.290 |
Why?
|
Psychiatric Status Rating Scales | 5 | 2017 | 6030 | 0.290 |
Why?
|
Nerve Net | 1 | 2019 | 2174 | 0.280 |
Why?
|
Female | 90 | 2023 | 379592 | 0.280 |
Why?
|
Motivation | 3 | 2021 | 1968 | 0.280 |
Why?
|
Object Attachment | 3 | 2018 | 313 | 0.280 |
Why?
|
Mental Health Services | 2 | 2012 | 1643 | 0.280 |
Why?
|
Male | 86 | 2022 | 349538 | 0.270 |
Why?
|
Propofol | 1 | 2012 | 628 | 0.270 |
Why?
|
Conversion Disorder | 2 | 2020 | 205 | 0.270 |
Why?
|
Health Services Accessibility | 3 | 2022 | 5133 | 0.270 |
Why?
|
Psychiatric Department, Hospital | 1 | 2006 | 135 | 0.270 |
Why?
|
Antidepressive Agents | 3 | 2011 | 2838 | 0.260 |
Why?
|
Internship and Residency | 4 | 2021 | 5774 | 0.260 |
Why?
|
Bradycardia | 1 | 2007 | 305 | 0.250 |
Why?
|
Cooperative Behavior | 3 | 2016 | 1503 | 0.250 |
Why?
|
Movement Disorders | 2 | 2018 | 444 | 0.250 |
Why?
|
Hospitalization | 7 | 2022 | 10232 | 0.250 |
Why?
|
Monocytes | 4 | 1998 | 2593 | 0.250 |
Why?
|
Angina Pectoris | 2 | 2001 | 977 | 0.240 |
Why?
|
Deception | 2 | 1995 | 99 | 0.240 |
Why?
|
Hypnotics and Sedatives | 1 | 2012 | 1158 | 0.240 |
Why?
|
Interdisciplinary Communication | 1 | 2010 | 950 | 0.240 |
Why?
|
Referral and Consultation | 6 | 2022 | 3527 | 0.240 |
Why?
|
Middle Aged | 52 | 2022 | 213127 | 0.240 |
Why?
|
Hyperparathyroidism | 1 | 2005 | 339 | 0.240 |
Why?
|
Placebo Effect | 2 | 2005 | 502 | 0.230 |
Why?
|
International Cooperation | 2 | 2012 | 1421 | 0.230 |
Why?
|
Models, Psychological | 3 | 2005 | 810 | 0.220 |
Why?
|
Coma | 1 | 2007 | 475 | 0.220 |
Why?
|
Adult | 62 | 2023 | 213712 | 0.220 |
Why?
|
Immune System | 4 | 2017 | 804 | 0.220 |
Why?
|
Severity of Illness Index | 11 | 2012 | 15530 | 0.220 |
Why?
|
Enkephalins | 3 | 2005 | 154 | 0.220 |
Why?
|
Hypercalcemia | 1 | 2005 | 405 | 0.220 |
Why?
|
Receptors, Opioid | 3 | 2017 | 155 | 0.220 |
Why?
|
Mass Screening | 5 | 2020 | 5238 | 0.220 |
Why?
|
Hallucinations | 2 | 2022 | 360 | 0.220 |
Why?
|
Social Support | 5 | 2019 | 2117 | 0.210 |
Why?
|
Invertebrates | 2 | 2002 | 50 | 0.210 |
Why?
|
Patient-Centered Care | 1 | 2013 | 1436 | 0.210 |
Why?
|
Sick Role | 4 | 1995 | 237 | 0.210 |
Why?
|
Developing Countries | 3 | 2018 | 2789 | 0.210 |
Why?
|
History, 20th Century | 4 | 2016 | 2739 | 0.210 |
Why?
|
Quinolones | 1 | 2005 | 366 | 0.210 |
Why?
|
Fear | 2 | 2023 | 1436 | 0.210 |
Why?
|
Brain Diseases | 2 | 2022 | 1554 | 0.210 |
Why?
|
Humanism | 2 | 1993 | 89 | 0.210 |
Why?
|
Acquired Immunodeficiency Syndrome | 3 | 2017 | 2231 | 0.210 |
Why?
|
Akinetic Mutism | 1 | 2021 | 11 | 0.210 |
Why?
|
Dyskinesias | 1 | 2022 | 78 | 0.200 |
Why?
|
Dopamine | 4 | 2005 | 1589 | 0.200 |
Why?
|
Social Adjustment | 3 | 2003 | 630 | 0.200 |
Why?
|
Music Therapy | 3 | 2013 | 100 | 0.200 |
Why?
|
Narcotics | 3 | 2005 | 343 | 0.200 |
Why?
|
Psychopharmacology | 1 | 2023 | 143 | 0.200 |
Why?
|
Hostility | 2 | 1999 | 189 | 0.200 |
Why?
|
Middle East | 2 | 2019 | 219 | 0.190 |
Why?
|
Diazepam | 3 | 2023 | 205 | 0.190 |
Why?
|
Syndrome | 4 | 2023 | 3248 | 0.190 |
Why?
|
Nervous System Physiological Phenomena | 3 | 2001 | 117 | 0.190 |
Why?
|
Interpersonal Relations | 2 | 2019 | 1423 | 0.190 |
Why?
|
Research Personnel | 2 | 2016 | 573 | 0.190 |
Why?
|
Pandemics | 7 | 2021 | 8328 | 0.190 |
Why?
|
Psychological Techniques | 1 | 2020 | 45 | 0.190 |
Why?
|
Ileus | 1 | 2020 | 58 | 0.180 |
Why?
|
Blood Cell Count | 2 | 2013 | 402 | 0.180 |
Why?
|
Military Personnel | 2 | 2019 | 1132 | 0.180 |
Why?
|
Diagnosis, Differential | 9 | 2012 | 12958 | 0.180 |
Why?
|
Limbic System | 3 | 2017 | 426 | 0.170 |
Why?
|
Telemedicine | 3 | 2022 | 2853 | 0.170 |
Why?
|
Somatoform Disorders | 2 | 2018 | 423 | 0.170 |
Why?
|
Aged | 32 | 2023 | 162944 | 0.170 |
Why?
|
Ethiopia | 2 | 2012 | 494 | 0.170 |
Why?
|
Personnel, Hospital | 1 | 2020 | 283 | 0.160 |
Why?
|
Endophenotypes | 1 | 2020 | 250 | 0.160 |
Why?
|
Coronavirus Infections | 3 | 2020 | 3130 | 0.160 |
Why?
|
Students | 2 | 2020 | 1647 | 0.160 |
Why?
|
Social Isolation | 2 | 2012 | 363 | 0.160 |
Why?
|
Sensation Disorders | 1 | 2019 | 156 | 0.150 |
Why?
|
Pneumonia, Viral | 3 | 2020 | 3236 | 0.150 |
Why?
|
Histiocytic Sarcoma | 1 | 1997 | 44 | 0.150 |
Why?
|
Cognition | 5 | 2022 | 6722 | 0.150 |
Why?
|
Brain | 10 | 2023 | 26343 | 0.150 |
Why?
|
Benzodiazepines | 5 | 2012 | 1101 | 0.150 |
Why?
|
Disease | 2 | 1993 | 681 | 0.150 |
Why?
|
Primary Health Care | 3 | 2010 | 4551 | 0.150 |
Why?
|
Vertebrates | 1 | 1998 | 227 | 0.150 |
Why?
|
Labor, Induced | 1 | 2018 | 146 | 0.150 |
Why?
|
Psychophysiology | 3 | 2001 | 135 | 0.140 |
Why?
|
Health Resources | 3 | 2020 | 911 | 0.140 |
Why?
|
Individuality | 1 | 2018 | 303 | 0.140 |
Why?
|
Attitude to Health | 4 | 2002 | 2051 | 0.140 |
Why?
|
Academic Medical Centers | 2 | 2011 | 2749 | 0.140 |
Why?
|
Dissociative Disorders | 1 | 2018 | 231 | 0.140 |
Why?
|
Vitamin D Deficiency | 1 | 2005 | 1331 | 0.130 |
Why?
|
Altruism | 1 | 2017 | 204 | 0.130 |
Why?
|
Job Satisfaction | 1 | 2019 | 535 | 0.130 |
Why?
|
Inpatients | 5 | 2022 | 2495 | 0.130 |
Why?
|
History, 21st Century | 2 | 2015 | 1533 | 0.130 |
Why?
|
Neurosecretory Systems | 1 | 2017 | 231 | 0.130 |
Why?
|
Electroencephalography | 7 | 2019 | 6142 | 0.130 |
Why?
|
Health Status | 4 | 2017 | 4030 | 0.130 |
Why?
|
Adult Survivors of Child Abuse | 1 | 2018 | 260 | 0.130 |
Why?
|
Chronic Disease | 4 | 2020 | 9144 | 0.130 |
Why?
|
Health Education | 1 | 2002 | 1053 | 0.130 |
Why?
|
Neutropenia | 1 | 2020 | 891 | 0.130 |
Why?
|
Piperazines | 1 | 2005 | 2488 | 0.130 |
Why?
|
Language Disorders | 2 | 1986 | 140 | 0.130 |
Why?
|
Psychometrics | 5 | 2018 | 2999 | 0.120 |
Why?
|
Cathexis | 1 | 1994 | 3 | 0.120 |
Why?
|
Pain | 5 | 2019 | 4961 | 0.120 |
Why?
|
General Adaptation Syndrome | 1 | 1994 | 6 | 0.120 |
Why?
|
Personality | 1 | 2018 | 548 | 0.120 |
Why?
|
Psychology | 2 | 1993 | 355 | 0.120 |
Why?
|
Seizures | 3 | 2022 | 2851 | 0.120 |
Why?
|
Fellowships and Scholarships | 2 | 2015 | 1066 | 0.120 |
Why?
|
Environment | 1 | 2020 | 1115 | 0.120 |
Why?
|
Quality of Life | 6 | 2021 | 12730 | 0.120 |
Why?
|
Forecasting | 3 | 2010 | 2948 | 0.120 |
Why?
|
Neuropsychological Tests | 6 | 2017 | 6974 | 0.120 |
Why?
|
Endothelium, Vascular | 4 | 2000 | 4455 | 0.120 |
Why?
|
Microglia | 2 | 2019 | 1261 | 0.120 |
Why?
|
Amygdala | 2 | 2020 | 1305 | 0.110 |
Why?
|
Schizophrenia, Paranoid | 3 | 2009 | 104 | 0.110 |
Why?
|
Workplace | 1 | 2019 | 836 | 0.110 |
Why?
|
Treatment Outcome | 14 | 2019 | 62966 | 0.110 |
Why?
|
Mind-Body Relations, Metaphysical | 2 | 2010 | 38 | 0.110 |
Why?
|
United States | 12 | 2022 | 69693 | 0.110 |
Why?
|
Macrophages | 3 | 2001 | 5655 | 0.110 |
Why?
|
Cytokines | 4 | 2023 | 7317 | 0.110 |
Why?
|
Prevalence | 8 | 2019 | 15194 | 0.110 |
Why?
|
Follow-Up Studies | 9 | 2018 | 39004 | 0.110 |
Why?
|
Respiratory Tract Infections | 1 | 2020 | 959 | 0.110 |
Why?
|
Haiti | 1 | 2014 | 551 | 0.110 |
Why?
|
Leukemia, Prolymphocytic, T-Cell | 1 | 2012 | 21 | 0.110 |
Why?
|
Prospective Studies | 12 | 2022 | 53187 | 0.110 |
Why?
|
Feasibility Studies | 4 | 2022 | 5062 | 0.110 |
Why?
|
Cost of Illness | 1 | 2022 | 1852 | 0.110 |
Why?
|
Allostasis | 1 | 2013 | 70 | 0.100 |
Why?
|
Schizophrenia | 5 | 2020 | 6874 | 0.100 |
Why?
|
Friends | 1 | 2013 | 153 | 0.100 |
Why?
|
Rwanda | 1 | 2014 | 704 | 0.100 |
Why?
|
Coronary Disease | 3 | 2000 | 6078 | 0.100 |
Why?
|
Comorbidity | 3 | 2018 | 10372 | 0.100 |
Why?
|
Fatal Outcome | 2 | 2012 | 1849 | 0.100 |
Why?
|
Herpesvirus 6, Human | 1 | 2012 | 95 | 0.100 |
Why?
|
Substance-Related Disorders | 5 | 2017 | 4250 | 0.100 |
Why?
|
Professional-Family Relations | 1 | 2016 | 481 | 0.100 |
Why?
|
Irritable Mood | 1 | 1993 | 183 | 0.100 |
Why?
|
International Educational Exchange | 1 | 2011 | 50 | 0.100 |
Why?
|
Combined Modality Therapy | 3 | 2013 | 8621 | 0.100 |
Why?
|
Inflammation | 4 | 2023 | 10578 | 0.100 |
Why?
|
Hypothalamo-Hypophyseal System | 3 | 2009 | 703 | 0.100 |
Why?
|
Socioeconomic Factors | 4 | 2020 | 7770 | 0.100 |
Why?
|
Psychotherapy | 1 | 2020 | 1644 | 0.100 |
Why?
|
Physician-Patient Relations | 4 | 2003 | 3215 | 0.100 |
Why?
|
Corticotropin-Releasing Hormone | 2 | 1994 | 369 | 0.100 |
Why?
|
Dopamine Agents | 1 | 2011 | 189 | 0.090 |
Why?
|
Pregnant Women | 1 | 2015 | 566 | 0.090 |
Why?
|
Biological Evolution | 5 | 2017 | 1074 | 0.090 |
Why?
|
South Australia | 1 | 2010 | 19 | 0.090 |
Why?
|
Emotions | 3 | 2021 | 2657 | 0.090 |
Why?
|
Anxiety, Separation | 2 | 2005 | 86 | 0.090 |
Why?
|
Creatine Kinase | 1 | 2013 | 694 | 0.090 |
Why?
|
Anti-Infective Agents | 1 | 1998 | 971 | 0.090 |
Why?
|
Crime | 2 | 2020 | 215 | 0.090 |
Why?
|
Heart Arrest | 2 | 1994 | 1469 | 0.090 |
Why?
|
Interviews as Topic | 1 | 2017 | 2536 | 0.090 |
Why?
|
Self-Injurious Behavior | 1 | 2015 | 462 | 0.090 |
Why?
|
Megacolon, Toxic | 1 | 2009 | 7 | 0.090 |
Why?
|
Professional Staff Committees | 1 | 2009 | 38 | 0.090 |
Why?
|
Vasoconstriction | 1 | 1993 | 596 | 0.090 |
Why?
|
Cardiac Surgical Procedures | 2 | 1996 | 3526 | 0.090 |
Why?
|
Electronic Mail | 1 | 2011 | 213 | 0.090 |
Why?
|
Pituitary-Adrenal System | 2 | 2008 | 553 | 0.090 |
Why?
|
Energy Metabolism | 2 | 2013 | 2896 | 0.090 |
Why?
|
Patient Selection | 1 | 2022 | 4214 | 0.090 |
Why?
|
Japan | 1 | 2014 | 1360 | 0.090 |
Why?
|
Irritable Bowel Syndrome | 1 | 2015 | 445 | 0.090 |
Why?
|
Reward | 2 | 2007 | 940 | 0.090 |
Why?
|
Postoperative Complications | 2 | 2008 | 15244 | 0.090 |
Why?
|
Videoconferencing | 1 | 2011 | 195 | 0.090 |
Why?
|
Cesarean Section | 1 | 2018 | 1363 | 0.090 |
Why?
|
Oxytocin | 2 | 2009 | 395 | 0.090 |
Why?
|
History, 19th Century | 2 | 2015 | 720 | 0.090 |
Why?
|
Peptide Fragments | 2 | 2000 | 5095 | 0.090 |
Why?
|
Serotonin Antagonists | 1 | 2009 | 146 | 0.090 |
Why?
|
Cyclophosphamide | 2 | 1997 | 2236 | 0.090 |
Why?
|
Electric Countershock | 2 | 1989 | 535 | 0.080 |
Why?
|
Family | 4 | 2013 | 3144 | 0.080 |
Why?
|
Puerperal Disorders | 2 | 2018 | 275 | 0.080 |
Why?
|
Amitriptyline | 1 | 1989 | 110 | 0.080 |
Why?
|
Qualitative Research | 1 | 2017 | 2680 | 0.080 |
Why?
|
Pregnancy Complications | 2 | 2018 | 2861 | 0.080 |
Why?
|
Tachycardia, Sinus | 1 | 2008 | 42 | 0.080 |
Why?
|
Hippocampus | 3 | 2012 | 3661 | 0.080 |
Why?
|
Societies, Scientific | 1 | 2009 | 220 | 0.080 |
Why?
|
Movement | 1 | 2015 | 1470 | 0.080 |
Why?
|
Community Health Services | 1 | 2014 | 650 | 0.080 |
Why?
|
Tacrolimus | 1 | 2012 | 741 | 0.080 |
Why?
|
Coronary Care Units | 1 | 2010 | 214 | 0.080 |
Why?
|
Electrophoresis, Agar Gel | 1 | 2008 | 212 | 0.080 |
Why?
|
Models, Biological | 4 | 2007 | 9581 | 0.080 |
Why?
|
Serotonin | 1 | 1993 | 1024 | 0.080 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 1998 | 2276 | 0.080 |
Why?
|
Gastrointestinal Motility | 1 | 2009 | 225 | 0.080 |
Why?
|
Medically Underserved Area | 1 | 2010 | 253 | 0.080 |
Why?
|
Kidney Failure, Chronic | 2 | 1992 | 2536 | 0.080 |
Why?
|
Emigrants and Immigrants | 1 | 2014 | 519 | 0.080 |
Why?
|
Leukodystrophy, Metachromatic | 1 | 1988 | 42 | 0.080 |
Why?
|
Motor Activity | 1 | 2018 | 2714 | 0.080 |
Why?
|
Life Change Events | 1 | 1993 | 937 | 0.080 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2021 | 9941 | 0.080 |
Why?
|
Self Care | 1 | 2013 | 786 | 0.070 |
Why?
|
Remote Consultation | 1 | 2010 | 238 | 0.070 |
Why?
|
Mental Status Schedule | 1 | 2008 | 321 | 0.070 |
Why?
|
Academies and Institutes | 1 | 2009 | 317 | 0.070 |
Why?
|
Lymphocytosis | 1 | 2008 | 119 | 0.070 |
Why?
|
Burning Mouth Syndrome | 1 | 2007 | 31 | 0.070 |
Why?
|
Alcohols | 1 | 2007 | 92 | 0.070 |
Why?
|
Signal Transduction | 6 | 2017 | 23387 | 0.070 |
Why?
|
Down-Regulation | 4 | 2007 | 3001 | 0.070 |
Why?
|
Cytochrome P-450 CYP2D6 | 1 | 2007 | 106 | 0.070 |
Why?
|
Neurotransmitter Agents | 3 | 1996 | 647 | 0.070 |
Why?
|
Animals | 22 | 2018 | 168561 | 0.070 |
Why?
|
Immunocompromised Host | 1 | 2012 | 847 | 0.070 |
Why?
|
Caregivers | 1 | 2018 | 2074 | 0.070 |
Why?
|
Panic Disorder | 2 | 2004 | 616 | 0.070 |
Why?
|
Death, Sudden | 2 | 1986 | 298 | 0.070 |
Why?
|
Behavior Therapy | 3 | 2001 | 866 | 0.070 |
Why?
|
Statistics, Nonparametric | 1 | 2012 | 2885 | 0.070 |
Why?
|
Dementia | 2 | 2008 | 2501 | 0.070 |
Why?
|
Recurrence | 2 | 2008 | 8333 | 0.070 |
Why?
|
Suicidal Ideation | 1 | 2015 | 1246 | 0.070 |
Why?
|
Autocrine Communication | 1 | 2007 | 171 | 0.070 |
Why?
|
Child Development Disorders, Pervasive | 1 | 2011 | 615 | 0.070 |
Why?
|
Autistic Disorder | 2 | 2011 | 1174 | 0.070 |
Why?
|
Diabetes Insipidus | 1 | 1987 | 151 | 0.070 |
Why?
|
Intensive Care Units | 1 | 1999 | 3679 | 0.070 |
Why?
|
Professional Competence | 1 | 2009 | 448 | 0.070 |
Why?
|
Compulsive Behavior | 1 | 1987 | 115 | 0.070 |
Why?
|
Aspirin | 1 | 1998 | 3278 | 0.070 |
Why?
|
Outpatients | 1 | 2014 | 1483 | 0.070 |
Why?
|
Drug Resistance | 2 | 2011 | 1608 | 0.070 |
Why?
|
Internationality | 1 | 2011 | 1002 | 0.070 |
Why?
|
Education, Medical | 3 | 2011 | 1717 | 0.070 |
Why?
|
Alcoholism | 2 | 2008 | 1904 | 0.070 |
Why?
|
Drinking | 1 | 1987 | 197 | 0.070 |
Why?
|
Paracrine Communication | 1 | 2007 | 276 | 0.070 |
Why?
|
Biomedical Research | 2 | 2015 | 3306 | 0.070 |
Why?
|
Child Behavior | 1 | 2011 | 838 | 0.070 |
Why?
|
Bulimia | 1 | 1988 | 381 | 0.070 |
Why?
|
Cross-Sectional Studies | 5 | 2022 | 24913 | 0.070 |
Why?
|
Peripheral Nervous System | 1 | 2006 | 150 | 0.070 |
Why?
|
Catechol O-Methyltransferase | 1 | 2007 | 245 | 0.070 |
Why?
|
Defibrillators, Implantable | 1 | 1994 | 1440 | 0.060 |
Why?
|
Suicide | 1 | 2015 | 1475 | 0.060 |
Why?
|
Electrocardiography | 2 | 2008 | 6440 | 0.060 |
Why?
|
Huntington Disease | 1 | 2011 | 1111 | 0.060 |
Why?
|
Cerebrospinal Fluid | 1 | 2008 | 534 | 0.060 |
Why?
|
Medicine in Literature | 1 | 1985 | 31 | 0.060 |
Why?
|
Brain Mapping | 3 | 2012 | 6669 | 0.060 |
Why?
|
Feedback, Physiological | 1 | 2007 | 479 | 0.060 |
Why?
|
Gene Expression Regulation | 4 | 2017 | 12071 | 0.060 |
Why?
|
Neurologic Examination | 1 | 2008 | 931 | 0.060 |
Why?
|
Basal Ganglia Diseases | 1 | 1985 | 149 | 0.060 |
Why?
|
Ambulatory Care Facilities | 2 | 2001 | 932 | 0.060 |
Why?
|
Role | 1 | 1985 | 175 | 0.060 |
Why?
|
Lupus Erythematosus, Systemic | 2 | 2002 | 2099 | 0.060 |
Why?
|
Bone Marrow Transplantation | 1 | 2012 | 2763 | 0.060 |
Why?
|
Culture | 2 | 2005 | 632 | 0.060 |
Why?
|
Drug Interactions | 1 | 2009 | 1458 | 0.060 |
Why?
|
Massachusetts | 3 | 2015 | 8662 | 0.060 |
Why?
|
Frontal Lobe | 2 | 2008 | 1407 | 0.060 |
Why?
|
Curriculum | 2 | 2014 | 3589 | 0.060 |
Why?
|
Substance Withdrawal Syndrome | 1 | 2008 | 633 | 0.060 |
Why?
|
Cerebral Cortex | 3 | 2017 | 5705 | 0.060 |
Why?
|
Peripheral Nervous System Diseases | 1 | 1989 | 700 | 0.060 |
Why?
|
Attention | 2 | 2006 | 2396 | 0.050 |
Why?
|
Narcissism | 1 | 1983 | 58 | 0.050 |
Why?
|
Juvenile Delinquency | 1 | 2003 | 125 | 0.050 |
Why?
|
Stress Disorders, Post-Traumatic | 1 | 2020 | 4248 | 0.050 |
Why?
|
Analgesics, Opioid | 2 | 2003 | 3667 | 0.050 |
Why?
|
Dracunculus Nematode | 1 | 2002 | 8 | 0.050 |
Why?
|
Internet | 2 | 2012 | 3062 | 0.050 |
Why?
|
Schizophrenic Psychology | 2 | 1987 | 1677 | 0.050 |
Why?
|
Bipolar Disorder | 3 | 2020 | 5024 | 0.050 |
Why?
|
Patient Acceptance of Health Care | 2 | 2014 | 3014 | 0.050 |
Why?
|
Risk Assessment | 4 | 2020 | 23320 | 0.050 |
Why?
|
Adolescent | 8 | 2023 | 85649 | 0.050 |
Why?
|
Blood Pressure | 1 | 2018 | 8541 | 0.050 |
Why?
|
Nicotine | 1 | 2007 | 677 | 0.050 |
Why?
|
Mood Disorders | 1 | 1989 | 1106 | 0.050 |
Why?
|
Psychotropic Drugs | 1 | 2008 | 893 | 0.050 |
Why?
|
Attitude to Death | 1 | 1985 | 382 | 0.050 |
Why?
|
Overweight | 1 | 2013 | 2366 | 0.050 |
Why?
|
Pregnancy | 6 | 2018 | 29087 | 0.050 |
Why?
|
Weight Loss | 1 | 2013 | 2604 | 0.050 |
Why?
|
Research Support as Topic | 1 | 2006 | 704 | 0.050 |
Why?
|
Ethanol | 1 | 2008 | 1337 | 0.050 |
Why?
|
Hematopoietic Stem Cells | 1 | 2014 | 3381 | 0.050 |
Why?
|
Education, Medical, Graduate | 1 | 2014 | 2283 | 0.050 |
Why?
|
N-Methylaspartate | 1 | 2022 | 231 | 0.050 |
Why?
|
Cocaine | 1 | 2007 | 1008 | 0.050 |
Why?
|
Protein Precursors | 3 | 2005 | 1154 | 0.050 |
Why?
|
Chest Pain | 1 | 2008 | 1113 | 0.050 |
Why?
|
Hydrocortisone | 4 | 2008 | 1825 | 0.050 |
Why?
|
Colon | 1 | 2009 | 1773 | 0.050 |
Why?
|
Functional Laterality | 1 | 2008 | 2290 | 0.050 |
Why?
|
Thoracic Surgical Procedures | 1 | 2005 | 341 | 0.050 |
Why?
|
Schistosoma mansoni | 1 | 2002 | 149 | 0.050 |
Why?
|
Behavior, Animal | 1 | 2009 | 1882 | 0.050 |
Why?
|
Enkephalin, Methionine | 2 | 2000 | 26 | 0.050 |
Why?
|
Age Distribution | 2 | 2018 | 2900 | 0.050 |
Why?
|
Psychological Theory | 1 | 2002 | 168 | 0.050 |
Why?
|
Risk Factors | 6 | 2018 | 72145 | 0.050 |
Why?
|
Leukopoiesis | 1 | 2020 | 56 | 0.050 |
Why?
|
Diseases in Twins | 1 | 1983 | 450 | 0.050 |
Why?
|
Terminally Ill | 2 | 1993 | 238 | 0.050 |
Why?
|
Young Adult | 8 | 2020 | 56350 | 0.050 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2015 | 2410 | 0.050 |
Why?
|
Valproic Acid | 1 | 2023 | 446 | 0.050 |
Why?
|
Patient Satisfaction | 1 | 2012 | 3391 | 0.040 |
Why?
|
Sleep | 1 | 2015 | 4604 | 0.040 |
Why?
|
Drug Tolerance | 2 | 2005 | 375 | 0.040 |
Why?
|
Cardiovascular Diseases | 4 | 2020 | 15108 | 0.040 |
Why?
|
Fatigue Syndrome, Chronic | 1 | 2001 | 214 | 0.040 |
Why?
|
Anger | 2 | 1994 | 402 | 0.040 |
Why?
|
Stroke | 1 | 2022 | 9963 | 0.040 |
Why?
|
Aged, 80 and over | 8 | 2022 | 57683 | 0.040 |
Why?
|
Molecular Sequence Data | 3 | 2008 | 18112 | 0.040 |
Why?
|
Median Eminence | 1 | 1999 | 37 | 0.040 |
Why?
|
Models, Neurological | 2 | 2005 | 1771 | 0.040 |
Why?
|
Marital Status | 1 | 2001 | 437 | 0.040 |
Why?
|
Hypertension | 2 | 2018 | 8455 | 0.040 |
Why?
|
Central Nervous System | 1 | 2006 | 1354 | 0.040 |
Why?
|
Adrenocorticotropic Hormone | 2 | 2002 | 648 | 0.040 |
Why?
|
Polymerase Chain Reaction | 1 | 2008 | 6171 | 0.040 |
Why?
|
Sequence Homology, Amino Acid | 2 | 2005 | 2837 | 0.040 |
Why?
|
Fetal Distress | 1 | 2018 | 40 | 0.040 |
Why?
|
Immunomodulation | 1 | 2022 | 540 | 0.040 |
Why?
|
Insulin | 1 | 2013 | 6575 | 0.040 |
Why?
|
Patient Dropouts | 1 | 2001 | 421 | 0.040 |
Why?
|
Trust | 1 | 2003 | 501 | 0.040 |
Why?
|
Whole Body Imaging | 1 | 2020 | 280 | 0.040 |
Why?
|
Plasma Exchange | 1 | 2019 | 155 | 0.040 |
Why?
|
Noise | 1 | 2020 | 279 | 0.040 |
Why?
|
Parent-Child Relations | 2 | 1993 | 747 | 0.040 |
Why?
|
Self Concept | 2 | 1995 | 1025 | 0.040 |
Why?
|
Wound Healing | 1 | 2009 | 2781 | 0.040 |
Why?
|
Drug Therapy, Combination | 1 | 2008 | 6483 | 0.040 |
Why?
|
Fetal Macrosomia | 1 | 2018 | 124 | 0.040 |
Why?
|
Diagnostic Errors | 1 | 1985 | 1255 | 0.040 |
Why?
|
Neurosecretion | 1 | 2017 | 11 | 0.040 |
Why?
|
Acute Coronary Syndrome | 1 | 2011 | 2337 | 0.040 |
Why?
|
Methylprednisolone | 1 | 2019 | 388 | 0.040 |
Why?
|
Macrophage Colony-Stimulating Factor | 1 | 1997 | 186 | 0.040 |
Why?
|
Protozoan Infections | 1 | 2017 | 39 | 0.040 |
Why?
|
Fetal Membranes, Premature Rupture | 1 | 2018 | 140 | 0.040 |
Why?
|
Gene Regulatory Networks | 2 | 2018 | 1707 | 0.040 |
Why?
|
Abruptio Placentae | 1 | 2018 | 118 | 0.040 |
Why?
|
Heart Diseases | 1 | 2010 | 2789 | 0.040 |
Why?
|
Patient Care | 2 | 1993 | 639 | 0.040 |
Why?
|
Delivery of Health Care | 1 | 2015 | 5304 | 0.040 |
Why?
|
Base Sequence | 1 | 2008 | 12797 | 0.040 |
Why?
|
Evidence-Based Medicine | 1 | 2009 | 3611 | 0.040 |
Why?
|
Brain Chemistry | 1 | 2000 | 981 | 0.040 |
Why?
|
Africa South of the Sahara | 1 | 2019 | 724 | 0.040 |
Why?
|
Psychoneuroimmunology | 1 | 1996 | 13 | 0.040 |
Why?
|
Neurodegenerative Diseases | 2 | 2002 | 1060 | 0.030 |
Why?
|
Vasculitis | 1 | 2020 | 521 | 0.030 |
Why?
|
Prisons | 1 | 2018 | 160 | 0.030 |
Why?
|
Morbidity | 1 | 2022 | 1767 | 0.030 |
Why?
|
Inflammation Mediators | 2 | 2017 | 1889 | 0.030 |
Why?
|
Arteriosclerosis | 2 | 2002 | 1092 | 0.030 |
Why?
|
Critical Illness | 1 | 2008 | 2665 | 0.030 |
Why?
|
Cohort Studies | 3 | 2022 | 40450 | 0.030 |
Why?
|
Psychology, Clinical | 1 | 2015 | 42 | 0.030 |
Why?
|
Human Rights | 1 | 2018 | 302 | 0.030 |
Why?
|
Rest | 1 | 2000 | 900 | 0.030 |
Why?
|
Stillbirth | 1 | 2018 | 346 | 0.030 |
Why?
|
Vasomotor System | 1 | 1996 | 209 | 0.030 |
Why?
|
Memory Disorders | 1 | 2022 | 1183 | 0.030 |
Why?
|
Glucocorticoids | 2 | 2019 | 2107 | 0.030 |
Why?
|
Saphenous Vein | 1 | 1998 | 531 | 0.030 |
Why?
|
Training Support | 1 | 2015 | 113 | 0.030 |
Why?
|
Universities | 1 | 2020 | 953 | 0.030 |
Why?
|
Estradiol | 2 | 2000 | 2021 | 0.030 |
Why?
|
Psychoses, Substance-Induced | 1 | 1995 | 96 | 0.030 |
Why?
|
Alkaloids | 1 | 1996 | 190 | 0.030 |
Why?
|
Host-Parasite Interactions | 1 | 2017 | 294 | 0.030 |
Why?
|
Chemotaxis | 1 | 1997 | 607 | 0.030 |
Why?
|
Postpartum Hemorrhage | 1 | 2018 | 258 | 0.030 |
Why?
|
Headache | 1 | 2022 | 1219 | 0.030 |
Why?
|
Calcium Channel Blockers | 1 | 1997 | 689 | 0.030 |
Why?
|
Breathing Exercises | 1 | 2014 | 53 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2007 | 10943 | 0.030 |
Why?
|
Ethics, Research | 1 | 2016 | 190 | 0.030 |
Why?
|
Rodentia | 1 | 1996 | 262 | 0.030 |
Why?
|
Fetal Growth Retardation | 1 | 2018 | 570 | 0.030 |
Why?
|
Kidney Transplantation | 1 | 1989 | 4246 | 0.030 |
Why?
|
Cell Size | 1 | 1996 | 643 | 0.030 |
Why?
|
Endorphins | 1 | 1994 | 75 | 0.030 |
Why?
|
Aggression | 1 | 2019 | 753 | 0.030 |
Why?
|
Prognosis | 2 | 2008 | 29010 | 0.030 |
Why?
|
Tegmentum Mesencephali | 1 | 1994 | 59 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 7 | 2020 | 35342 | 0.030 |
Why?
|
Status Epilepticus | 1 | 2019 | 444 | 0.030 |
Why?
|
Heart Function Tests | 1 | 1994 | 330 | 0.030 |
Why?
|
Antibiotics, Antineoplastic | 1 | 1997 | 692 | 0.030 |
Why?
|
Genes, fos | 1 | 1994 | 183 | 0.030 |
Why?
|
Paraventricular Hypothalamic Nucleus | 1 | 1994 | 113 | 0.030 |
Why?
|
Focus Groups | 1 | 2018 | 1320 | 0.030 |
Why?
|
Emergency Service, Hospital | 1 | 2013 | 7645 | 0.030 |
Why?
|
Antineoplastic Agents, Alkylating | 1 | 1997 | 627 | 0.030 |
Why?
|
History, Early Modern 1451-1600 | 1 | 1993 | 3 | 0.030 |
Why?
|
History, Modern 1601- | 1 | 1993 | 16 | 0.030 |
Why?
|
Dementia, Multi-Infarct | 1 | 1993 | 12 | 0.030 |
Why?
|
Shyness | 1 | 1993 | 21 | 0.030 |
Why?
|
Neprilysin | 1 | 1996 | 439 | 0.030 |
Why?
|
Child | 5 | 2023 | 77478 | 0.030 |
Why?
|
AIDS Dementia Complex | 1 | 1994 | 152 | 0.030 |
Why?
|
History, Medieval | 1 | 1993 | 63 | 0.030 |
Why?
|
Perception | 2 | 2001 | 1188 | 0.030 |
Why?
|
Chemotaxis, Leukocyte | 1 | 1996 | 675 | 0.030 |
Why?
|
Ventricular Fibrillation | 2 | 1986 | 538 | 0.030 |
Why?
|
MMPI | 1 | 1993 | 86 | 0.030 |
Why?
|
Program Evaluation | 2 | 2012 | 2485 | 0.030 |
Why?
|
Congenital Abnormalities | 1 | 2018 | 707 | 0.030 |
Why?
|
Rats | 4 | 2012 | 24265 | 0.030 |
Why?
|
Cultural Competency | 1 | 2016 | 288 | 0.030 |
Why?
|
Retrospective Studies | 5 | 2022 | 77098 | 0.030 |
Why?
|
Locus Coeruleus | 1 | 1994 | 176 | 0.030 |
Why?
|
Macrophage Activation | 1 | 1996 | 558 | 0.030 |
Why?
|
Lymphocyte Subsets | 1 | 1994 | 315 | 0.030 |
Why?
|
Gonadotropin-Releasing Hormone | 1 | 1999 | 1185 | 0.030 |
Why?
|
Lipoproteins, LDL | 1 | 1996 | 628 | 0.030 |
Why?
|
History, Ancient | 1 | 1993 | 212 | 0.030 |
Why?
|
Guilt | 1 | 1993 | 95 | 0.030 |
Why?
|
Group Processes | 1 | 2014 | 225 | 0.030 |
Why?
|
Carbidopa | 1 | 2011 | 31 | 0.030 |
Why?
|
Dance Therapy | 1 | 2011 | 8 | 0.030 |
Why?
|
Chemokine CXCL12 | 1 | 2014 | 462 | 0.030 |
Why?
|
RNA, Messenger | 1 | 2007 | 13029 | 0.030 |
Why?
|
Amantadine | 1 | 2011 | 55 | 0.030 |
Why?
|
Receptors, Estrogen | 1 | 2000 | 2186 | 0.030 |
Why?
|
Neuronal Ceroid-Lipofuscinoses | 1 | 1993 | 142 | 0.030 |
Why?
|
Age Factors | 1 | 2009 | 18355 | 0.030 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2013 | 3920 | 0.030 |
Why?
|
Avoidance Learning | 1 | 1993 | 233 | 0.020 |
Why?
|
Income | 1 | 2020 | 1904 | 0.020 |
Why?
|
Cell Adhesion | 1 | 1998 | 3139 | 0.020 |
Why?
|
Drug Combinations | 2 | 2011 | 1961 | 0.020 |
Why?
|
Doxorubicin | 1 | 1997 | 2215 | 0.020 |
Why?
|
Parkinson Disease | 1 | 2005 | 2774 | 0.020 |
Why?
|
Social Environment | 2 | 2009 | 1023 | 0.020 |
Why?
|
Levodopa | 1 | 2011 | 218 | 0.020 |
Why?
|
Sympathetic Nervous System | 1 | 1994 | 514 | 0.020 |
Why?
|
Species Specificity | 1 | 1995 | 2479 | 0.020 |
Why?
|
Coronary Artery Bypass | 1 | 2000 | 2281 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2006 | 14720 | 0.020 |
Why?
|
Hyperlipidemias | 1 | 1996 | 786 | 0.020 |
Why?
|
Demography | 1 | 2015 | 1650 | 0.020 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2009 | 5171 | 0.020 |
Why?
|
Autoantibodies | 1 | 2019 | 2036 | 0.020 |
Why?
|
Bromocriptine | 1 | 2010 | 111 | 0.020 |
Why?
|
Homeostasis | 2 | 2008 | 3335 | 0.020 |
Why?
|
Educational Status | 2 | 2013 | 2533 | 0.020 |
Why?
|
Cell Membrane | 1 | 2000 | 3744 | 0.020 |
Why?
|
Immunologic Deficiency Syndromes | 1 | 1994 | 546 | 0.020 |
Why?
|
Positron-Emission Tomography | 2 | 2019 | 6259 | 0.020 |
Why?
|
Anti-HIV Agents | 1 | 2005 | 4250 | 0.020 |
Why?
|
Religion | 1 | 2013 | 356 | 0.020 |
Why?
|
Rats, Sprague-Dawley | 2 | 2012 | 8300 | 0.020 |
Why?
|
Clinical Competence | 1 | 2005 | 4681 | 0.020 |
Why?
|
Affect | 1 | 2017 | 1473 | 0.020 |
Why?
|
Electrolytes | 1 | 2010 | 282 | 0.020 |
Why?
|
Time Factors | 5 | 2020 | 40054 | 0.020 |
Why?
|
Patient Discharge | 1 | 2022 | 3300 | 0.020 |
Why?
|
Receptors, Cell Surface | 1 | 1999 | 2867 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2018 | 21719 | 0.020 |
Why?
|
Fluoxetine | 1 | 1993 | 749 | 0.020 |
Why?
|
Patient Care Team | 1 | 2000 | 2527 | 0.020 |
Why?
|
Autoimmunity | 1 | 2017 | 1348 | 0.020 |
Why?
|
Propensity Score | 1 | 2015 | 1771 | 0.020 |
Why?
|
Life Style | 3 | 2010 | 3824 | 0.020 |
Why?
|
Recovery of Function | 1 | 2019 | 2924 | 0.020 |
Why?
|
Cell Communication | 1 | 1996 | 1619 | 0.020 |
Why?
|
Poverty | 1 | 2020 | 2646 | 0.020 |
Why?
|
China | 1 | 2014 | 2246 | 0.020 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2018 | 8925 | 0.020 |
Why?
|
Hospitals | 1 | 2022 | 3937 | 0.020 |
Why?
|
Personal Satisfaction | 1 | 1993 | 634 | 0.020 |
Why?
|
Mammals | 1 | 1994 | 1135 | 0.020 |
Why?
|
Dilatation, Pathologic | 1 | 2009 | 520 | 0.020 |
Why?
|
S-Nitroso-N-Acetylpenicillamine | 1 | 2007 | 23 | 0.020 |
Why?
|
Mortality | 1 | 2019 | 2857 | 0.020 |
Why?
|
gamma-Aminobutyric Acid | 1 | 1994 | 1123 | 0.020 |
Why?
|
Dopamine Agonists | 1 | 2010 | 355 | 0.020 |
Why?
|
Information Dissemination | 1 | 2016 | 1100 | 0.020 |
Why?
|
Immunity, Cellular | 1 | 1994 | 1606 | 0.020 |
Why?
|
Suicide, Attempted | 1 | 2015 | 1218 | 0.020 |
Why?
|
Water Intoxication | 1 | 1987 | 11 | 0.020 |
Why?
|
Disease Susceptibility | 1 | 2014 | 1780 | 0.020 |
Why?
|
Single-Blind Method | 1 | 2011 | 1589 | 0.020 |
Why?
|
NG-Nitroarginine Methyl Ester | 1 | 2007 | 255 | 0.020 |
Why?
|
Heart Failure | 1 | 2011 | 10856 | 0.020 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2002 | 3915 | 0.020 |
Why?
|
Healthcare Disparities | 1 | 2022 | 3151 | 0.020 |
Why?
|
Analgesics, Non-Narcotic | 1 | 2010 | 365 | 0.020 |
Why?
|
Lung Neoplasms | 2 | 2009 | 13019 | 0.020 |
Why?
|
Patient Education as Topic | 1 | 2017 | 2275 | 0.020 |
Why?
|
Regression Analysis | 2 | 2011 | 6452 | 0.020 |
Why?
|
Animals, Newborn | 1 | 2012 | 2723 | 0.020 |
Why?
|
Calcium | 1 | 2000 | 5753 | 0.020 |
Why?
|
Gene Expression | 1 | 2020 | 7790 | 0.020 |
Why?
|
Urban Population | 1 | 2015 | 2018 | 0.020 |
Why?
|
Checklist | 1 | 2014 | 830 | 0.020 |
Why?
|
Blood Coagulation Disorders | 1 | 2009 | 337 | 0.020 |
Why?
|
Tachycardia, Supraventricular | 1 | 1989 | 263 | 0.020 |
Why?
|
Death, Sudden, Cardiac | 1 | 1994 | 1541 | 0.020 |
Why?
|
Schools | 1 | 2015 | 1425 | 0.020 |
Why?
|
Fluid Therapy | 1 | 2010 | 592 | 0.020 |
Why?
|
Activities of Daily Living | 1 | 1995 | 2414 | 0.020 |
Why?
|
Premature Birth | 1 | 2018 | 1713 | 0.020 |
Why?
|
Amnesia | 1 | 1988 | 244 | 0.020 |
Why?
|
Environmental Exposure | 1 | 2020 | 4231 | 0.020 |
Why?
|
Disease Progression | 1 | 2022 | 13256 | 0.020 |
Why?
|
Pain Measurement | 1 | 1995 | 3418 | 0.020 |
Why?
|
Dantrolene | 1 | 1985 | 26 | 0.020 |
Why?
|
Adjustment Disorders | 1 | 1985 | 70 | 0.020 |
Why?
|
Dominance, Cerebral | 1 | 1986 | 635 | 0.020 |
Why?
|
Medial Forebrain Bundle | 1 | 1985 | 45 | 0.020 |
Why?
|
Psychopathology | 1 | 1988 | 402 | 0.020 |
Why?
|
Naloxone | 1 | 2007 | 367 | 0.020 |
Why?
|
Cells, Cultured | 2 | 1997 | 19223 | 0.020 |
Why?
|
Nitric Oxide Synthase | 2 | 1999 | 916 | 0.020 |
Why?
|
Cardiovascular Agents | 1 | 2011 | 848 | 0.020 |
Why?
|
Trifluoperazine | 1 | 1983 | 40 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2020 | 13921 | 0.020 |
Why?
|
Hospital Mortality | 1 | 2018 | 5310 | 0.020 |
Why?
|
Neural Pathways | 1 | 1995 | 2971 | 0.010 |
Why?
|
Boston | 2 | 2011 | 9305 | 0.010 |
Why?
|
Guidelines as Topic | 1 | 2010 | 1402 | 0.010 |
Why?
|
Neoplasms | 1 | 1993 | 21596 | 0.010 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2012 | 2013 | 0.010 |
Why?
|
Technology Assessment, Biomedical | 1 | 1986 | 307 | 0.010 |
Why?
|
Abdomen | 1 | 2009 | 1107 | 0.010 |
Why?
|
Individuation | 1 | 1983 | 23 | 0.010 |
Why?
|
Human Growth Hormone | 1 | 2008 | 683 | 0.010 |
Why?
|
Faculty, Medical | 1 | 2011 | 1182 | 0.010 |
Why?
|
HIV Infections | 1 | 2009 | 16678 | 0.010 |
Why?
|
Abdominal Pain | 1 | 2009 | 1059 | 0.010 |
Why?
|
Ego | 1 | 1983 | 96 | 0.010 |
Why?
|
Shock, Septic | 1 | 2009 | 773 | 0.010 |
Why?
|
Narcotic Antagonists | 1 | 2007 | 562 | 0.010 |
Why?
|
Tachycardia | 1 | 1985 | 620 | 0.010 |
Why?
|
Morphine Derivatives | 1 | 2002 | 44 | 0.010 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2007 | 1213 | 0.010 |
Why?
|
Personality Development | 1 | 1983 | 245 | 0.010 |
Why?
|
Public Health | 1 | 2015 | 2594 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2020 | 19862 | 0.010 |
Why?
|
Saliva | 1 | 2006 | 805 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2018 | 9410 | 0.010 |
Why?
|
Injections, Intravenous | 1 | 1983 | 1420 | 0.010 |
Why?
|
Coronary Vessels | 1 | 1993 | 3099 | 0.010 |
Why?
|
Intelligence | 1 | 2006 | 920 | 0.010 |
Why?
|
Physicians | 1 | 2019 | 4554 | 0.010 |
Why?
|
Micrococcus luteus | 1 | 2000 | 4 | 0.010 |
Why?
|
Twins, Monozygotic | 1 | 1983 | 458 | 0.010 |
Why?
|
Incidence | 1 | 1999 | 20928 | 0.010 |
Why?
|
Cerebral Infarction | 1 | 1986 | 1007 | 0.010 |
Why?
|
Amino Acid Sequence | 2 | 2005 | 13814 | 0.010 |
Why?
|
Spectrometry, Mass, Electrospray Ionization | 1 | 2002 | 276 | 0.010 |
Why?
|
Child, Preschool | 2 | 2015 | 40955 | 0.010 |
Why?
|
Coronary Artery Disease | 2 | 2002 | 6454 | 0.010 |
Why?
|
Pregnancy Complications, Neoplastic | 1 | 2003 | 253 | 0.010 |
Why?
|
Patient Compliance | 1 | 2011 | 2680 | 0.010 |
Why?
|
Immune System Diseases | 1 | 2003 | 262 | 0.010 |
Why?
|
Tissue Donors | 1 | 1989 | 2205 | 0.010 |
Why?
|
Registries | 1 | 2015 | 8077 | 0.010 |
Why?
|
Psychomotor Performance | 1 | 2008 | 1895 | 0.010 |
Why?
|
Mitochondria | 1 | 2013 | 3520 | 0.010 |
Why?
|
Postoperative Period | 1 | 2005 | 1839 | 0.010 |
Why?
|
Mental Recall | 1 | 2006 | 1205 | 0.010 |
Why?
|
Diagnostic Tests, Routine | 1 | 1986 | 783 | 0.010 |
Why?
|
Estrogen Antagonists | 1 | 2000 | 151 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2007 | 4751 | 0.010 |
Why?
|
Reaction Time | 1 | 2006 | 2092 | 0.010 |
Why?
|
Hypothalamus | 1 | 1985 | 1063 | 0.010 |
Why?
|
Intracellular Membranes | 1 | 2000 | 390 | 0.010 |
Why?
|
Linear Models | 1 | 2009 | 5948 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2013 | 12017 | 0.010 |
Why?
|
Utilization Review | 1 | 2000 | 392 | 0.010 |
Why?
|
Leukocytes | 1 | 2007 | 2039 | 0.010 |
Why?
|
Acute Disease | 1 | 2009 | 7141 | 0.010 |
Why?
|
Reference Values | 1 | 2006 | 4982 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2014 | 10472 | 0.010 |
Why?
|
Radiography | 1 | 2009 | 7010 | 0.010 |
Why?
|
Mesencephalon | 1 | 2000 | 327 | 0.010 |
Why?
|
Serum Albumin, Bovine | 1 | 1999 | 324 | 0.010 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2002 | 1574 | 0.010 |
Why?
|
Guanylate Cyclase | 1 | 1999 | 201 | 0.010 |
Why?
|
Exercise | 1 | 2014 | 5611 | 0.010 |
Why?
|
Gram-Positive Bacterial Infections | 1 | 2000 | 341 | 0.010 |
Why?
|
Cerebrovascular Disorders | 1 | 1985 | 1499 | 0.010 |
Why?
|
Health Promotion | 1 | 2010 | 2194 | 0.010 |
Why?
|
Immunoblotting | 1 | 2000 | 1683 | 0.010 |
Why?
|
Bivalvia | 1 | 1996 | 53 | 0.010 |
Why?
|
Escherichia coli Infections | 1 | 2000 | 532 | 0.010 |
Why?
|
Evolution, Molecular | 1 | 2005 | 1937 | 0.010 |
Why?
|
Survival Analysis | 1 | 2009 | 10248 | 0.010 |
Why?
|
Nitric Oxide Synthase Type III | 1 | 1999 | 689 | 0.010 |
Why?
|
Dexamethasone | 1 | 1983 | 1949 | 0.010 |
Why?
|
Aortic Aneurysm, Abdominal | 1 | 2005 | 1181 | 0.010 |
Why?
|
Tamoxifen | 1 | 2000 | 980 | 0.010 |
Why?
|
Hospitals, Teaching | 1 | 2000 | 1179 | 0.010 |
Why?
|
Breast Neoplasms | 1 | 2003 | 20774 | 0.010 |
Why?
|
Age of Onset | 1 | 2002 | 3266 | 0.010 |
Why?
|
Anticoagulants | 1 | 2010 | 4595 | 0.010 |
Why?
|
Arteries | 1 | 2000 | 1118 | 0.010 |
Why?
|
Rats, Wistar | 1 | 1999 | 1902 | 0.010 |
Why?
|
Arousal | 1 | 2000 | 1165 | 0.010 |
Why?
|
Palliative Care | 1 | 1989 | 3478 | 0.010 |
Why?
|
Respiration | 1 | 2000 | 1645 | 0.010 |
Why?
|
Models, Immunological | 1 | 1996 | 527 | 0.010 |
Why?
|
Epilepsy, Tonic-Clonic | 1 | 1993 | 49 | 0.010 |
Why?
|
Heart Ventricles | 1 | 1985 | 3801 | 0.010 |
Why?
|
Enzyme Activation | 1 | 1999 | 3701 | 0.010 |
Why?
|
Risk | 1 | 1985 | 9679 | 0.010 |
Why?
|
Staphylococcus aureus | 1 | 2000 | 1449 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 2010 | 7153 | 0.010 |
Why?
|
Staphylococcal Infections | 1 | 2000 | 1398 | 0.010 |
Why?
|
Obesity | 1 | 2013 | 12705 | 0.010 |
Why?
|
Bone Neoplasms | 1 | 2003 | 2522 | 0.010 |
Why?
|
Decision Making | 1 | 2003 | 3869 | 0.010 |
Why?
|
Testosterone | 1 | 1999 | 2401 | 0.000 |
Why?
|
Escherichia coli | 1 | 2000 | 4214 | 0.000 |
Why?
|
Cost-Benefit Analysis | 1 | 2000 | 5385 | 0.000 |
Why?
|
Mice | 1 | 2014 | 81045 | 0.000 |
Why?
|
Sex Factors | 1 | 2001 | 10392 | 0.000 |
Why?
|
Hospital Bed Capacity, 500 and over | 1 | 1986 | 115 | 0.000 |
Why?
|
Enzyme Inhibitors | 1 | 1996 | 3800 | 0.000 |
Why?
|
Predictive Value of Tests | 1 | 2001 | 15056 | 0.000 |
Why?
|
Electrodes, Implanted | 1 | 1989 | 824 | 0.000 |
Why?
|
New York | 1 | 1986 | 886 | 0.000 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2003 | 11472 | 0.000 |
Why?
|
Biopsy | 1 | 1993 | 6756 | 0.000 |
Why?
|